The Efficacy of Unified Transdiagnostic Therapy in Reducing Worry, Anxiety, Depressive Sympotom and Emotion Regulation in Patients With Generalized Anxiety Disorder

Not Applicable

Conditions: Generalized Anxiety Disorder.
Generalized anxiety disorder
F41.1

Registration Number: IRCT20100614004178N3

Lead Sponsor: Shelir Kolahzari

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 20

Inclusion Criteria

Being resident in sanandaj)
Having generalized anxiety disorder symptoms based on psychiatric or clinical psychologists diagnosis according to SCID-1
Having motivation and satisfaction for attending in treatment sessions
level of education :Having at least high school diploma

Exclusion Criteria

diagnosis of any comorbid disorders except for anxiety and depression which has been mentioned in the research
having major depressive disorder (MDD)
having psychotic symptoms and drug abuse and suicidal thoughts
having all symptoms of personality disorders according to DSM-5

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anxiety score in beck anxiety inventory. Timepoint: pre and post treatment and after 1month follow up. Method of measurement: beck depression inventory 2, beck anxiety inventory,.

Secondary Outcome Measures

Name	Time	Method
Anxiety. Timepoint: pre and post treatment and after 3 month fallow up. Method of measurement: Beck anxiety inventory.;Depression. Timepoint: pre and post treatment and after 3 month fallow up. Method of measurement: beck depression inventory.;Woryy. Timepoint: pre and post treatment and after 3 month fallow up. Method of measurement: Pennsylvania worry questionnaire.;Emotion regulation. Timepoint: pre and post treatment and after 3 month fallow up. Method of measurement: difficulties in emotion regulation questionnaire.